ICMR Report Reveals Decline in Antibiotic Effectiveness

A new ICMR report highlights a worrying trend of antibiotic resistance in India, with only 18.4% of E. coli samples showing susceptibility to cefotaxime.

A
Aapla Nagpur Desk
22 Nov 2026, 6:22 AM IST · 2 min read
Source: TOI
ICMR Report Reveals Decline in Antibiotic Effectiveness
KEY TAKEAWAYS
1

Only 18.4% of E. coli samples are susceptible to cefotaxime.

2

High resistance rates found in Klebsiella pneumoniae and Acinetobacter baumannii.

3

Government emphasizes the need for responsible antibiotic use amid rising resistance.

A recent report from the Indian Council of Medical Research (ICMR) has raised alarms about the diminishing effectiveness of common antibiotics used to treat bacterial infections. The report indicates that merely 18.4% of E. coli samples collected from hospitals were susceptible to cefotaxime, an antibiotic critical for treating severe infections like pneumonia and urinary tract infections (UTIs). This revelation comes as the government intensifies its focus on the misuse of antibiotics, coinciding with the launch of World Antimicrobial Resistance Awareness Week on November 18.

During this awareness week, the health ministry underscored the alarming trend of antibiotic sales occurring without prescriptions and inappropriate prescribing practices. The ICMR's annual report for 2025, which monitors antimicrobial resistance, also revealed significant resistance to stronger antibiotics. Notably, only about one-third of Klebsiella pneumoniae samples were found to be susceptible to carbapenems, a class of antibiotics typically reserved for severe infections that do not respond to other treatments.

Further compounding the issue, the report found that a staggering 91.1% of Acinetobacter baumannii isolates tested were resistant to carbapenems. This particular bacterium is known to cause severe hospital-acquired infections, including pneumonia and bloodstream infections, especially among critically ill patients. Dr. Kamini Walia, who leads ICMR’s descriptive research division, emphasized that antimicrobial resistance is not limited to major referral centers, highlighting concerning trends in secondary-care hospitals as well.

The data revealed a significant decline in ceftriaxone susceptibility among E. coli samples, dropping from 39.8% in category I hospitals to just 11.5% in category III hospitals. This trend indicates a growing public health challenge that could lead to increased morbidity and mortality rates if not addressed promptly. The findings call for immediate action to improve antibiotic stewardship and ensure that these vital medications remain effective for future generations.

Looking ahead, health authorities are expected to implement stricter regulations on antibiotic prescriptions and sales, alongside public awareness campaigns aimed at educating both healthcare providers and the public about the dangers of antibiotic misuse. Continued monitoring and research will be crucial in combating this rising threat of antimicrobial resistance in India.

💬What did you think of this story?What did you think?

Read Next